In its UDRHP-I filing to Sebi, the company any 'adverse' outcome in legal proceedings involving Zostel may materially and adversely affect its business, reputation, prospects, results of operation and financial condition, including potential issuance or transfer of up to 7% of its shareholding.
PRISM's recent IPO filing with Sebi has highlighted potential significant risks stemming from its ongoing legal dispute with Zostel. The company states that any adverse outcome in these legal proceedings could materially and adversely affect its business, reputation, and overall…
Market Samachar is a news aggregator. This article was originally published by Markets-Economic Times. Tap the button above to read the full story on their site.